Assenagon Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Assenagon Asset Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-867,233	Closed	-$1.49M	–	1510
2023 Q3	$1.49M	Sell	867,233 -381,031	-31%	-$676K	﹤0.01%	952
2023 Q2	$2.43M	Sell	1,248,264 -290,104	-19%	-$679K	0.01%	701
2023 Q1	$4.28M	Sell	1,538,368 -407,332	-21%	-$1.16M	0.02%	611
2022 Q4	$6.71M	Buy	1,945,700 +1,181,630	+155%	+$3.37M	0.02%	469
2022 Q3	$1.96M	Sell	764,070 -227,402	-23%	-$724K	0.01%	722
2022 Q2	$2.4M	Buy	+991,472	New	+$2.6M	0.01%	765

Other funds holding GRTS

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Assenagon Asset Management's GRTS Position: Q4 2023 in Review

Assenagon Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 867,233 shares — an estimated $1.49M sold.

Assenagon Asset Management first reported a position in GRTS in Q2 2022 and held it in 6 quarters. The position peaked at $6.71M in Q4 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

Assenagon Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Assenagon Asset Management sold 867,233 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $1.49M.
Assenagon Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Assenagon Asset Management's Gritstone bio, Inc. Common Stock position peaked at $6.71M in Q4 2022.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Assenagon Asset Management's 13F filing for Q4 2023, filed 17 Jan 2024.